Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Glucagon-like peptide-1(7-36) amide is a new incretin/enterogastrone candidate.

× No keyword cloud information.

15 in total

1. Antidiabetogenic action of truncated glucagon-like peptide-1 in mice.

Authors: B Ahrén
Journal: Endocrine Date: 1995-05 Impact factor: 3.633

Review 2. Targeting the CNS to treat type 2 diabetes.

Authors: Darleen A Sandoval; Silvana Obici; Randy J Seeley
Journal: Nat Rev Drug Discov Date: 2009-05 Impact factor: 84.694

3. Metabolic and endocrine functions of glucagon-like peptides - evolutionary and biochemical perspectives.

Authors: T P Mommsen; E M Plisetskaya
Journal: Fish Physiol Biochem Date: 1993-07 Impact factor: 2.794

4. Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.

Authors: J Schirra; K Sturm; P Leicht; R Arnold; B Göke; M Katschinski
Journal: J Clin Invest Date: 1998-04-01 Impact factor: 14.808

5. Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice.

Authors: T Linn; K Schneider; B Göke; K Federlin
Journal: Acta Diabetol Date: 1996-03 Impact factor: 4.280

6. Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons.

Authors: D A D'Alessio; R Vogel; R Prigeon; E Laschansky; D Koerker; J Eng; J W Ensinck
Journal: J Clin Invest Date: 1996-01-01 Impact factor: 14.808

7. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats.

Authors: Adam P Chambers; Lene Jessen; Karen K Ryan; Stephanie Sisley; Hilary E Wilson-Pérez; Margaret A Stefater; Shrawan G Gaitonde; Joyce E Sorrell; Mouhamadoul Toure; Jose Berger; David A D'Alessio; Stephen C Woods; Randy J Seeley; Darleen A Sandoval
Journal: Gastroenterology Date: 2011-07-12 Impact factor: 22.682

8. Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.

Authors: D A D'Alessio; S E Kahn; C R Leusner; J W Ensinck
Journal: J Clin Invest Date: 1994-05 Impact factor: 14.808

9. Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7-36 amide] in the fasting state in healthy subjects.

Authors: C Qualmann; M A Nauck; J J Holst; C Orskov; W Creutzfeldt
Journal: Acta Diabetol Date: 1995-03 Impact factor: 4.280

Review 10. CNS GLP-1 regulation of peripheral glucose homeostasis.

Authors: Darleen Sandoval
Journal: Physiol Behav Date: 2008-05-27